HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hirohiko Tsujii Selected Research

Radiotherapy

11/2012Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.
4/2012[Heavy ion radiotherapy for malignant tumors: current status and future direction].
4/2012Results of carbon ion radiotherapy for head and neck cancer.
4/2012Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck.
6/2011Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.
1/2011Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: prognostic value of pretreatment apparent diffusion coefficient (ADC).
8/2010Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy - relation to prognosis and liver function.
8/2010Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis.
6/2010[Particle therapy--carbon ion radiotherapy for non-small cell lung cancer].
4/2010Dose-volume histogram and dose-surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Hirohiko Tsujii Research Topics

Disease

34Neoplasms (Cancer)
04/2012 - 04/2002
9Melanoma (Melanoma, Malignant)
04/2012 - 10/2004
8Carcinoma (Carcinomatosis)
09/2007 - 09/2003
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2010 - 09/2004
6Prostatic Neoplasms (Prostate Cancer)
11/2012 - 02/2004
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2010 - 02/2002
5Sarcoma (Soft Tissue Sarcoma)
04/2012 - 11/2002
4Lung Neoplasms (Lung Cancer)
04/2009 - 02/2002
3Hepatocellular Carcinoma (Hepatoma)
08/2010 - 08/2004
3Adenocarcinoma
01/2010 - 06/2003
3Neoplasm Metastasis (Metastasis)
05/2009 - 04/2002
2Head and Neck Neoplasms (Head and Neck Cancer)
04/2012 - 10/2004
2Adenoid Cystic Carcinoma (Cylindroma)
04/2012 - 10/2004
2Chordoma
09/2009 - 09/2004
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2007 - 10/2004
1Colonic Neoplasms (Colon Cancer)
05/2011
1Fibrosis (Cirrhosis)
05/2011
1Rectal Neoplasms (Rectal Cancer)
11/2008
1Radiation Pneumonitis (Radiation Fibrosis)
10/2007
1Carcinoma in Situ
03/2007
1Neovascular Glaucoma
02/2007
1Hemorrhage
01/2007
1Major Depressive Disorder (Major Depressive Disorders)
08/2006
1Adjustment Disorders (Adjustment Disorder)
08/2006
1Anoxia (Hypoxia)
04/2006
1Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2006
1Second Primary Neoplasms (Neoplasms, Second)
01/2006
1Brain Neoplasms (Brain Tumor)
09/2005
1Wounds and Injuries (Trauma)
10/2004
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2004
1Uterine Neoplasms (Uterine Cancer)
10/2004
1Hemangiosarcoma (Angiosarcoma)
10/2004
1Esophageal Neoplasms (Esophageal Cancer)
09/2004
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2004
1Chromosome Aberrations (Chromosome Abnormalities)
06/2004
1Fibrosarcoma
06/2004
1Lung Injury
10/2003

Drug/Important Bio-Agent (IBA)

49CarbonIBA
11/2012 - 02/2002
6IonsIBA
04/2012 - 06/2004
2Direction compoundIBA
04/2012 - 06/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2009 - 06/2003
2Cisplatin (Platino)FDA LinkGeneric
03/2008 - 11/2007
2Protons (Proton)IBA
03/2007 - 09/2003
1Histone Deacetylase InhibitorsIBA
11/2009
1cyclic hydroxamic acid-containing peptide 31IBA
11/2009
1Ephrin-A1 (Ephrin A1)IBA
01/2009
1HormonesIBA
11/2008
1methionine methyl esterIBA
11/2008
1tumor suppressor protein p73IBA
03/2008
1Laminin (Merosin)IBA
11/2007
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2007
1DNA (Deoxyribonucleic Acid)IBA
06/2007
1ChromatinIBA
03/2007
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
08/2006
1OxygenIBA
04/2006
1Contrast MediaIBA
01/2005
1Cyclin D1IBA
09/2004
1Proteins (Proteins, Gene)IBA
09/2004
1Gadolinium DTPA (Magnevist)FDA Link
06/2004
1Methionine (L-Methionine)FDA Link
03/2004
1Dihydrotachysterol (AT 10)IBA
09/2003
1Formaldehyde (Formol)FDA Link
06/2003
1ParaffinIBA
06/2003
1Thymidine PhosphorylaseIBA
06/2003
1Choline (Choline Chloride)IBA
04/2002
1Amino AcidsFDA Link
04/2002

Therapy/Procedure

50Radiotherapy
11/2012 - 11/2002
2Aftercare (After-Treatment)
08/2010 - 11/2008
2Lasers (Laser)
05/2009 - 03/2007
2Brachytherapy
09/2007 - 01/2005
1Heterologous Transplantation (Xenotransplantation)
05/2011
1Drug Therapy (Chemotherapy)
01/2011
1Immunotherapy
08/2010
1Activities of Daily Living (ADL)
04/2009
1Pancreaticoduodenectomy
01/2007
1Intravenous Injections
01/2005
1Pancreatectomy
10/2004
1Neoadjuvant Therapy
04/2002